Canada markets closed

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1163-0.0054 (-4.44%)
At close: 03:51PM EDT

Khiron Life Sciences Corp.

2300-550 Burrard Street
Vancouver, BC V6C 2B5
Canada

https://khiron.ca

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Alvaro Francisco TorresCo-Founder, CEO & Director269.51kN/A1980
Mr. Swapan Kakumanu ACA, ACWA, CGACFO & Corp. Sec.N/AN/A1970
Mr. Manuel BuendiaVP of OperationsN/AN/AN/A
Mr. Luis ChavezCountry Mang. of MexicoN/AN/AN/A
Mr. Marco AlgortaCountry Mang. of UruguayN/AN/AN/A
Ms. Franziska KatterbachPres of Khiron EuropeN/AN/AN/A
Mr. Juan Diego AlvarezVP of RegulationsN/AN/A1985
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Corporate Governance

Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.